Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neoplasms × Mindfulness × Clear all

Phase

Status

Sponsor Class

OTHER 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Surveys and Questionnaires 2 Proton Therapy 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Music Therapy 2 Mesna 2 Melphalan 2 Interviews as Topic 2 Gene Expression Profiling 2 Cyclophosphamide 2 Busulfan 2 tremelimumab 1 motesanib diphosphate 1 luprolide acetate gel depot 1 liposomal amphotericin B 1 durvalumab 1 copanlisib 1 chlorhexidine gluconate 1 batifiban 1 Whole Genome Sequencing 1 Watchful Waiting 1 Thrombopoietin 1 Taxes 1 Spermine Synthase 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05470010 2026-03-27

SEAMLESS

Canadian Cancer Trials Group

Phase NA Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡